Generate a tailored SOP for Dr. Susanne Kossatz. Improve your application with a focused, well-structured draft.
Prof. Susanne Kossatz's research interests are centered on the development and clinical translation of molecular imaging tools aimed at improving tumor detection, intraoperative delineation, and treatment monitoring, with the overarching goal of enhancing patient survival outcomes. Her work involves investigating the suitability of fluorescent nuclear imaging probes for molecular imaging applications, along with preclinical validation and clinical translation initiatives. Prof. Kossatz studied Biology at Friedrich Schiller University Jena and obtained her Ph.D. in Molecular Imaging in 2013. She further advanced her academic career through postdoctoral studies at Memorial Sloan Kettering Cancer Center in New York from 2014 to 2019, focusing on the preclinical evaluation and clinical translation of fluorescently and radioactively labeled PARP inhibitors. Since April 2019, she has been leading a research group titled 'Imaging Biomarkers in Oncology' within the Department of Nuclear Medicine at the Technical University of Munich (TUM).
Technical University of Munich • Munich, Germany
Leads the research group 'Imaging Biomarkers in Oncology' in the Department of Nuclear Medicine.